Sagimet Biosciences (SGMT) EBT (2022 - 2026)
Sagimet Biosciences (SGMT) recorded quarterly EBT of -$10.6 million in Q1 2026, down 11.31% quarter-over-quarter from -$9.6 million in Q4 2025, and up 41.41% on a YoY basis from -$7.5 million in Q1 2025.
Sagimet Biosciences (SGMT) EBT (2022 - 2026) Analysis & Trends
Sagimet Biosciences' EBT history runs 5 years deep, the most recent figure standing at -$10.6 million for Q1 2026.
- In Q1 2026, EBT rose 41.41% year-over-year to -$10.6 million; the TTM figure through Mar 2026 stood at -$43.5 million (up 23.82% YoY), while the FY2025 annual figure was -$51.0 million, down 12.01% from the prior year.
- EBT was -$10.6 million for Q1 2026 at Sagimet Biosciences, down from -$9.6 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$6.4 million in Q3 2023 to a low of -$18.2 million in Q1 2025.
- Historically, EBT has averaged -$9.8 million across 5 years, with a median of -$8.1 million in 2023.
- The sharpest annual moves came in 2025 and 2026: EBT plunged 174.19% in 2025, then soared 41.41% in 2026.
- A 5-year view of EBT shows it stood at -$7.2 million in 2022, then dropped by 13.3% to -$8.2 million in 2023, then sank by 98.74% to -$16.2 million in 2024, then soared by 40.94% to -$9.6 million in 2025, then dropped by 11.31% to -$10.6 million in 2026.
- The last three EBT figures came in at -$10.6 million (Q1 2026), -$9.6 million (Q4 2025), and -$12.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -56.48 Mn |
| 10 | Sagimet Biosciences | 211.96 Mn | 211.96 Mn | - | -10.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.65 Mn |
| Dec 31, 2025 | -9.57 Mn |
| Sep 30, 2025 | -12.91 Mn |
| Jun 30, 2025 | -10.39 Mn |
| Mar 31, 2025 | -18.18 Mn |
| Dec 31, 2024 | -16.20 Mn |
| Sep 30, 2024 | -14.62 Mn |
| Jun 30, 2024 | -8.12 Mn |
| Mar 31, 2024 | -6.63 Mn |
| Dec 31, 2023 | -8.15 Mn |
| Sep 30, 2023 | -6.36 Mn |
| Jun 30, 2023 | -6.79 Mn |
| Mar 31, 2023 | -6.59 Mn |
| Dec 31, 2022 | -7.20 Mn |
| Sep 30, 2022 | -7.47 Mn |
| Jun 30, 2022 | -7.10 Mn |